From February 5 to 8, the 41st Asia-Pacific Academy of Ophthalmology Congress (APAO 2026) was grandly held in Hong Kong, China. Under the theme "Looking to the Future, Innovating Ophthalmology", this congress was held together with the 37th Hong Kong Ophthalmological Symposium, gathering more than 11,000 eye health professionals from 111 countries and regions. Zhang Jing, Assistant to the Chief President of Ming Vision & Ophthalmology, Li Chen, Director of the Special Examination Center, and Wang Mingyan, a doctoral candidate, attended the congress as representatives and delivered keynote presentations. Among them, Li Chen was honored with the APAO Best Scientific Paper Award.

The on-site presentation delivered by Director Li Chen was titled "Comparing Early Visual Quality: SMILE Pro (VisuMax 800) vs SMILE (VisuMax 500)". It presented the clinical results and early visual quality observations of the team led by Professor Zhou Yuehua of Beijing Ming Vision & Ophthalmology, which was among the first to launch SMILE Pro in May 2025. The study of this center showed that both SMILE Pro and SMILE have high safety and efficacy. In addition, compared with conventional SMILE, SMILE Pro offers better clinical predictability, more accurate astigmatism correction, as well as certain advantages in early visual quality. This presentation was finally awarded the APAO Best Scientific Paper Award.

Since May 2025, the new-generation ZEISS robotic SMILE platform VISUMAX 800 has been installed and put into use for the first time at Beijing Ming Vision & Ophthalmology. As one of the first users in China of the new-generation ZEISS minimally invasive SMILE VISUMAX 800, Ming Vision & Ophthalmology, under the leadership of Professor Zhou Yuehua and Professor Li Ying, now has 5 certified experts for the new SMILE procedure, ranking among the top in the country in both surgical volume and the number of certified doctors.

Dr. Zhang Jing spoke in the cornea session of the congress and delivered a keynote report titled "Sharing of the Clinical Effect of Scleral Lens Fitting after Corneal Cross-Linking for Keratoconus". The report explained in detail that corneal collagen cross-linking halts the progression of keratoconus, that scleral lens fitting can further improve the visual quality of patients, and that the correction effect of scleral lenses is effective and stable over the long term, making it an effective means of improving the visual quality of keratoconus patients after cross-linking surgery.

The diagnosis of typical keratoconus is not difficult, but the clinical manifestations in the early stage of the disease are atypical, which makes diagnosis somewhat challenging. Keratoconus screening and treatment is one of the distinctive technologies of Ming Vision & Ophthalmology, aiming to provide patients with one-stop precise and personalized diagnosis and treatment.

The presentation by doctoral candidate Wang Mingyan was titled "Comparison of Postoperative Outcomes of SMILE 4.0 Guided by Cycloplegic and Manifest Refractive". It presented the VISULYZE-generated nomogram-assisted precise SMILE 4.0 surgery carried out by the team of Professor Zhou Yuehua. By comparing the postoperative outcomes of the cycloplegic refraction input group with those of the manifest refraction input group, the study further verified the efficacy, stability and predictability of both approaches in the correction of myopia and astigmatism, and showed that cycloplegic refraction yields better correction predictability in terms of postoperative spherical equivalent. At the same time, it provided valuable experience for creating a 4.0 nomogram, ensuring a wide distribution of refractive errors, and establishing a personalized 4.0 nomogram database for each doctor.